This Week in Neurology: Parkinson Disease Management and Stroke Intervention Strategies
Research this week highlighted various pharmacological and therapeutic approaches for managing motor symptoms in Parkinson disease. In the Journal of Neurology, a network meta-analysis of randomized controlled trials evaluated adjunct therapies for Asian patients experiencing motor fluctuations [3].
The analysis suggested that safinamide 100 mg outperformed both rasagiline 1 mg and zonisamide 25 mg in reducing OFF-time and improving motor scores [3].
Additionally, research published in Neurology reported on the use of fecal microbiota transplantation (FMT) for patients with mild to moderate Parkinson disease [5].
A meta-analysis of 220 adults found that FMT significantly improved constipation symptoms and motor function as measured by UPDRS part III, though the authors noted these effects may be transient [5].
Regarding stroke management and cardiovascular interventions, a study in the Journal of the American Heart Association provided a post-hoc analysis of a multicenter Phase 3 randomized controlled trial involving 1577 ischemic stroke patients who presented within 4.5 hours of onset [2].
The researchers reported that tenecteplase showed no significant difference in the distribution of serious adverse events when compared to alteplase [2].
Another study published in Circulation evaluated a Phase 3 randomized controlled trial involving 500 adults with stroke and elevated blood pressure [4].
The findings suggested that the PINGS intervention, which utilized mobile health tools and nurse case management, improved systolic blood pressure control to 67% compared to 43% in those receiving usual care [4].
Finally, a report in the Journal of the American College of Cardiology discussed transcatheter aortic valve replacement for patients with severe symptomatic aortic stenosis at low surgical risk [1].
The study found mortality rates to be comparable to surgical replacement, though it noted that transcatheter procedures may involve higher risks of regurgitation requiring reintervention [1].